Member Info for aj242

I’m attending AACR (virtually) so can report back

Read the RNS for the 8th of feb too...

Great post penance. Well articulated. On the wine again.

It’s also clearly stated in the RNS announcing partnership with mologic....better than an interview

Anyway, this will drop tomorrow, it’s PI driven so expect a reasonable drop (as usual). Still a long way to go and £2 is the target for starts

You lot need to stop bickering. Who gives a toss if mologic test is crap, odx will make avactas test and make millions. ITS A WIN WIN FFS

Clearly states it in the RNS

That’s a completely rubbish example considering they are still waiting for clinical trial results

There was NEVER going to be a placement here. Just idiotic derampers talking nonsence

Yes it would definitely hit the avct SP, no doubt about that. I guess the USP with avct is affirmers and it being able to capture most/all variants. Time will tell.

While I agree that if the government choose avacta over molOgic, I don’t understand how ODX would have known that the avacta test would have been superior at the time given that they had not received any specificity or sensitivity data So I think what you are saying can be deemed as quite harsh

great RNS- thank god. Nice to see I was totally wrong about the price movement on Friday. Onwards...

I didn’t know “around the end of q1” was last week regulator! As I said, I’m a holder of both, and much before you even knew what odx is, so I’m happy with the rns for both reasons, more confirmation we will be making everything that comes our way and that will include avactas test ;)

Great RNS and great news all round. We will be making tests, regardless who’s it is! But also great to see confirmation that the UKs test of choice is very very likely to be avactas. Now we can all get along.

Totally agree that theoretically, RT should be “easier” however, RT affects the tumour micro environment quite differently to chemotherapy. There is also lots of hype around RT and immunotherapy combinations where RT is seen to increase PDL1 expression on tumour cells and T cells in the TME to enable a better killing effect by the drug by blocking pd-1/pd-l1 and pd-l1/b7.1

thats great filter. I still need another 200% but in time, hopefully we will surpass that

ok I concede, this isnt a usual pump and dump, however it isn't completely unusual either. We have seen it happen before but rarely, lets see what Monday holds. Slightly more optimistic!

why? a government contract has been announced and we are simply waiting on avacta to confirm their test. If you don't have the confidence then sell.

you do understand that they HAVE to publish that as an RNS, its not pointless. If you have confidence in your investment, you wouldn't post such nonsence

nice and confident there. Like I mentioned before, I can't see why they would put this out if they weren't confident of securing planning.

Fair enough aberdeenman.

Anyway normal service to resume shortly